skip to main content
Resultados 1 2 3 4 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma

Ribas, Antoni ; Lawrence, Donald ; Atkinson, Victoria ; Agarwal, Sachin ; Miller, Jr, Wilson H ; Carlino, Matteo S ; Fisher, Rosalie ; Long, Georgina V ; Hodi, F Stephen ; Tsoi, Jennifer ; Grasso, Catherine S ; Mookerjee, Bijoyesh ; Zhao, Qing ; Ghori, Razi ; Moreno, Blanca Homet ; Ibrahim, Nageatte ; Hamid, Omid

Nature medicine, 2019-06, Vol.25 (6), p.936-940 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

2
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

Ascierto, Paolo Antonio ; Ferrucci, Pier Francesco ; Fisher, Rosalie ; Del Vecchio, Michele ; Atkinson, Victoria ; Schmidt, Henrik ; Schachter, Jacob ; Queirolo, Paola ; Long, Georgina V ; Di Giacomo, Anna Maria ; Svane, Inge Marie ; Lotem, Michal ; Bar-Sela, Gil ; Couture, Felix ; Mookerjee, Bijoyesh ; Ghori, Razi ; Ibrahim, Nageatte ; Moreno, Blanca Homet ; Ribas, Antoni

Nature medicine, 2019-06, Vol.25 (6), p.941-946 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

3
Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients
Material Type:
Artigo
Adicionar ao Meu Espaço

Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients

Takezako, Naoki ; Kosugi, Hiroshi ; Matsumoto, Morio ; Iida, Shinsuke ; Ishikawa, Takayuki ; Kondo, Yukio ; Ando, Kiyoshi ; Miki, Hirokazu ; Matsumura, Itaru ; Sunami, Kazutaka ; Teshima, Takanori ; Iwasaki, Hiromi ; Onishi, Yasushi ; Kizaki, Masahiro ; Izutsu, Koji ; Maruyama, Dai ; Tobinai, Kensei ; Ghori, Razi ; Farooqui, Mohammed ; Liao, Jason ; Marinello, Patricia ; Matsuda, Kenji ; Koh, Yasuhiro ; Shimamoto, Takashi ; Suzuki, Kenshi

International journal of hematology, 2020-11, Vol.112 (5), p.640-649 [Periódico revisado por pares]

Texto completo disponível

4
KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma
Material Type:
Artigo
Adicionar ao Meu Espaço

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

Ferrucci, Pier Francesco ; Di Giacomo, Anna Maria ; Del Vecchio, Michele ; Atkinson, Victoria ; Schmidt, Henrik ; Schachter, Jacob ; Queirolo, Paola ; Long, Georgina V ; Stephens, Rosalie ; Svane, Inge Marie ; Lotem, Michal ; Abu-Amna, Mahmoud ; Gasal, Eduard ; Ghori, Razi ; Diede, Scott J ; Croydon, Elizabeth S ; Ribas, Antoni ; Ascierto, Paolo Antonio

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001806 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

5
P628: UPDATED ANALYSIS OF BELLWAVE‐001: A PHASE 1/2 OPEN‐LABEL DOSE‐EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B‐CELL MALIGNANCIES
Material Type:
Artigo
Adicionar ao Meu Espaço

P628: UPDATED ANALYSIS OF BELLWAVE‐001: A PHASE 1/2 OPEN‐LABEL DOSE‐EXPANSION STUDY OF THE EFFICACY AND SAFETY OF NEMTABRUTINIB FOR THE TREATMENT OF B‐CELL MALIGNANCIES

Woyach, Jennifer ; Flinn, Ian W. ; Awan, Farrukh ; Eradat, Herbert ; Brander, Danielle M. ; Tees, Michael ; Parikh, Sameer ; Phillips, Tycel ; Ghori, Razi ; Paydar, Ima ; Farooqui, Mohammed Z. H. ; Byrd, John C. ; Stephens, Deborah

HemaSphere, 2023-08, Vol.7 (S3), p.e7809236-n/a [Periódico revisado por pares]

Philadelphia, PA: Lippincott Williams & Wilkins

Texto completo disponível

6
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Marabelle, Aurelien ; Le, Dung T ; Ascierto, Paolo A ; Di Giacomo, Anna Maria ; De Jesus-Acosta, Ana ; Delord, Jean-Pierre ; Geva, Ravit ; Gottfried, Maya ; Penel, Nicolas ; Hansen, Aaron R ; Piha-Paul, Sarina A ; Doi, Toshihiko ; Gao, Bo ; Chung, Hyun Cheol ; Lopez-Martin, Jose ; Bang, Yung-Jue ; Frommer, Ronnie Shapira ; Shah, Manisha ; Ghori, Razi ; Joe, Andrew K ; Pruitt, Scott K ; Diaz, Jr, Luis A

Journal of clinical oncology, 2020-01, Vol.38 (1), p.1-10 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

7
Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Pembrolizumab combined with carfilzomib and low‐dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE‐023 study

Moreau, Philippe ; Ghori, Razi ; Farooqui, Mohammed ; Marinello, Patricia ; San Miguel, Jesus

British journal of haematology, 2021-07, Vol.194 (1), p.e48-e51 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

8
Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study
Material Type:
Artigo
Adicionar ao Meu Espaço

Pembrolizumab combined with lenalidomide and low‐dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE‐023 study

Mateos, Maria‐Victoria ; Orlowski, Robert Z. ; Ocio, Enrique M. ; Rodríguez‐Otero, Paula ; Reece, Donna ; Moreau, Philippe ; Munshi, Nikhil ; Avigan, David E. ; Siegel, David S. ; Ghori, Razi ; Farooqui, Mohammed Z. H. ; Marinello, Patricia ; San-Miguel, Jesus

British journal of haematology, 2019-09, Vol.186 (5), p.e117-e121 [Periódico revisado por pares]

England: Blackwell Publishing Ltd

Texto completo disponível

9
Efficacy and Safety of Nemtabrutinib, a Wild-Type and C481S-Mutated Bruton Tyrosine Kinase Inhibitor for B-Cell Malignancies: Updated Analysis of the Open-Label Phase 1/2 Dose-Expansion Bellwave-001 Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Efficacy and Safety of Nemtabrutinib, a Wild-Type and C481S-Mutated Bruton Tyrosine Kinase Inhibitor for B-Cell Malignancies: Updated Analysis of the Open-Label Phase 1/2 Dose-Expansion Bellwave-001 Study

Woyach, Jennifer A. ; Flinn, Ian W. ; Awan, Farrukh T. ; Eradat, Herbert ; Brander, Danielle ; Tees, Michael ; Parikh, Sameer A. ; Phillips, Tycel J. ; Ghori, Razi ; Reddy, Nishitha M. ; Farooqui, Mohammed Z.H. ; Byrd, John C. ; Stephens, Deborah M.

Blood, 2022-11, Vol.140 (Supplement 1), p.7004-7006 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

10
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

Usmani, Saad Zafar ; Schjesvold, Fredrik ; Oriol, Albert ; Karlin, Lionel ; Cavo, Michele ; LeBlanc, Richard ; Takezako, Naoki ; Lim, Andrew Boon Ming ; Suzuki, Kenshi ; Kosugi, Hiroshi ; Grigoriadis, George ; Avivi, Irit ; Facon, Thierry ; Jagannath, Sundar ; Lonial, Sagar ; Ghori, Razi Uddin ; Farooqui, Mohammed Z H ; Marinello, Patricia ; Lim, Andrew ; Grigoriadis, George ; Walker, Trish ; Nicol, Andrew ; LeBlanc, Richard ; Reece, Donna ; Elemary, Mohamed ; Karlin, Lionel ; Attal, Michel ; Engelhardt, Monika ; Mackensen, Andreas ; Quinn, John ; Avivi, Irit ; Cohen, Amos ; Magen-Nativ, Hila ; Cavo, Michele ; Larocca, Alessandra ; Takezako, Naoki ; Suzuki, Kenshi ; Kosugi, Hiroshi ; Matsumoto, Morio ; Iida, Shinsuke ; Ishikawa, Takayuki ; Kondo, Yukio ; Sunami, Kazutaka ; Ando, Kiyoshi ; Teshima, Takanori ; Chou, Takaaki ; Iwasaki, Hiromi ; Miki, Hirokazu ; Matsumura, Itaru ; Onishi, Yasushi ; Izutsu, Koji ; Kizaki, Masahiro ; George, Anupkumar ; Blacklock, Hillary ; Schjesvold, Fredrik ; Waage, Anders ; Nikitin, Evgeniy ; Chagorova, Tatiana ; McDonald, Andrew ; Patel, Moosa ; Oriol Rocafiguera, Albert ; San Miguel Izquierdo, Jesus ; Mateos, Maria ; Streetly, Matthew ; Forsyth, Peter ; Jackson, Graham ; Jenkins, Stephen ; Rifkin, Robert ; Yimer, Habte ; McCroskey, Robert ; Martincic, Danko ; Tarantolo, Stefano ; Larson, Sarah ; Faroun, Yacoub ; Vaughn, Jennifer ; Saylors, Gene ; Fung, Henry ; Stevens, Don ; Coleman, Morton ; Costa, Dennis ; Cross, Scott ; Fanning, Suzanne ; Berges, Daniel Farray ; Harris, Thomas ; Zackon, Ira ; Atanackovic, Djordje ; Oliff, Ira ; Lee, Wes ; Bensinger, William ; Lutzky, Jose ; Baron, Ari ; Kirschner, Eli ; Bharany, Neeraj ; Overton, Lindsay ; Mannem, Siva ; Harroff, Allyson ; Jain, Sharad ; Roque, Tammy ; Yasencha, Christopher K ; Houck, William

The Lancet. Haematology, 2019-09, Vol.6 (9), p.e448-e458 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (29)
  2. Revistas revisadas por pares (28)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (30)
  2. Anais de Congresso  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de2017  (2)
  2. 2017Até2018  (2)
  3. 2019Até2020  (14)
  4. 2021Até2023  (12)
  5. Após 2023  (2)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.